OAP, 84, becomes world's oldest volunteer for coronavirus vaccine
Pensioner, 84, becomes world’s oldest volunteer to receive injection of potential vaccine for coronavirus
- Xiong Zhengxing, 84, received the vaccine on Monday during its second trial
- He is the world’s oldest person to get a shot of a possible coronavirus vaccine
- China launched its first clinical trial for the inactivated vaccination in late March
- All participants from the first trial returned home and are said to remain healthy
- A total of three potential vaccinations for the virus have started testing in China
- Learn more about how to help people impacted by COVID
An elderly resident in China has become the world’s oldest volunteer to receive a potential coronavirus vaccination.
Xiong Zhengxing, 84, along with his daughter, Xiong Ying, participated in the second trial of the vaccine candidate in Wuhan on Monday. They are said to remain healthy.
The vaccine, which was developed by the country’s top military bio-warfare expert, is one of China’s three potential vaccinations for the deadly disease that has infected over two million people worldwide.
All the participants from the first trial have remained healthy and returned home after 14-day medical observation, according to the press.
Xiong Zhengxing (middle), 84, along with his daughter, Xiong Ying (left), participated in the second trial of the vaccine candidate in Wuhan on Monday. They are said to remain healthy
The researchers recruited 500 new volunteers after starting the second trial on Sunday. 273 participants have received injections by the end of Monday, Chinese media report.
It is the first COVID-19 vaccine candidate in the world that has entered the second phase of clinical trials, according to state media Xinhua.
Mr Xiong requested to be a volunteer after his daughter, who is a paediatrician, was selected as a participant.
‘I signed up for my dad after the researchers told me that there was no age limit,’ said Ms Xiong.
Elderly residents who are over the 60s were allowed to participate in the second trial after the age limit was removed. A placebo-controlled group was also introduced to the second trial to evaluate the safety and efficacy of the potential vaccine.
‘It’s been over a day [since the injections], we feel fine,’ Ms Xiong added. ‘Our temperatures are normal as well.’
The 84-year-old retired soldier, Xiong Zhengxing, is considered to be the world’s oldest volunteer for a potential coronavirus vaccine. He is pictured receiving the injection
The 84-year-old retired soldier is considered to be the world’s oldest volunteer for a potential coronavirus vaccine.
‘As long as it’s something beneficial for the people and the country and I’m capable, I would do it,’ the pensioner told Pear Video.
Chen Wei, the lead researcher, told the press that the vaccination needs to protect elderly people who are more susceptible to the killer bug.
The Recombinant Novel Coronavirus Vaccine was successfully developed following over a month of research, including the study of the vaccines for Ebola.
The first clinical trial for the vaccination was given a green light in mid-March. A total of 108 healthy adults, aged between 18 and 60, volunteered to receive the injections.
They were divided into three groups which were injected with different amounts of the inactivated vaccine.
All the participants of the first trial have completed their 14-day quarantine and returned home.
‘My health has been absolutely fine during this period. I don’t feel sick or painful anywhere,’ a participant told Pear Video as he was leaving the facility.
‘There was a slight pain in where I was injected for the initial few days.
‘I feel very confident about the vaccine,’ he added. ‘I believe it will be introduced to the public very soon.’
Another volunteer told the press that she has returned to her daily life after ‘everything feels normal.’
‘It felt nothing different from receiving a regular injection, like being bitten by a mosquito,’ said Jin Guanping to Southern Metropolis Daily.
The research team will monitor all the volunteers for another six months and take their blood samples to examine the antibodies.
Scientists said that they plan to conduct additional trials overseas if the vaccine is proved to be effective and safe.
The news comes as another Beijing-based company Sinovac Biotech has secured approval in China to move ahead with a human clinical trial for its vaccine candidate on Monday.
China’s CanSino Biologics also begun its second phase of testing its vaccine candidate, China’s Ministry of Science and Technology said on Tuesday.
This means that three potential COVID-19 vaccinations are making fast progress in their testing in China.
Meanwhile, Oxford University scientists are confident they can get the jab for the incurable disease rolled out for millions to use by autumn.
Oxford’s vaccine programme has already recruited 510 people, aged between 18 and 55, to take part in the first trial.
More than 70 vaccines are currently in development, according to the World Health Organization (WHO).
The first group of Chinese volunteers who received potential coronavirus vaccinations have claimed to maintain good health after finishing two-week quarantine for observation
The Recombinant Novel Coronavirus Vaccine was successfully developed following more than a month of research. Chen Wei (right), is pictured with two medical researchers in Wuhan
Source: Read Full Article